Related Experiment Video
Updated: Jan 30, 2026

08:46
Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice
Published on: January 26, 2024
2.5K
Bacteriophage interactions with mammalian tissue: Therapeutic applications
Haein Huh1, Shirley Wong1, Jesse St Jean1
1School of Pharmacy, University of Waterloo, 10A Victoria St S, Kitchener N2G 1C5, Canada.
Advanced Drug Delivery Reviews
|January 20, 2019
Summary
Human bacteriophages (phages) interact with hosts, impacting health. This review explores how phages cross mammalian barriers for therapeutic potential.
Area of Science:
- Microbiology
- Virology
- Human Health
Background:
- The human body hosts numerous bacteriophages (phages), bacterial viruses with significant roles in host interactions.
- Phages are increasingly explored for therapeutic applications, including engineered phage therapies.
- Understanding phage interactions with mammalian cells and tissues remains limited despite growing clinical interest.
Purpose of the Study:
- To review direct evidence of bacteriophage accumulation in various mammalian tissues.
- To highlight the unique ability of phages to traverse biological barriers.
- To discuss the relevance of phage barrier traversal to therapeutic applications.
Main Methods:
- Literature review of studies investigating bacteriophage presence and distribution in mammalian tissues.
- Analysis of experimental data demonstrating phage penetration of physiological barriers.
- Synthesis of findings related to phage-host interactions and therapeutic potential.
Main Results:
- Bacteriophages are found in diverse human tissues, including those previously considered sterile.
- Phages exhibit a remarkable capacity to bypass anatomical and physiological barriers in mammals.
- Evidence supports phage accumulation in tissues, suggesting active or passive transport mechanisms.
Conclusions:
- Phages possess unique capabilities to traverse mammalian biological barriers.
- This traversal ability is crucial for understanding phage-host dynamics and developing phage-based therapies.
- Further research into phage barrier-crossing mechanisms is essential for optimizing therapeutic strategies.
Related Concept Videos
Lysogenic Cycle of Bacteriophages
67.9K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
67.9K
Lytic Cycle of Bacteriophages
77.9K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.9K
DNA Bacteriophages
988
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
988
Therapeutic Index
6.8K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.8K
Therapeutic Communication
8.0K
Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
8.0K
Cholinergic Antagonists: Therapeutic Uses
1.5K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.5K

